Thumbnail Image
Publication

The Impact of Prior Authorization on Buprenorphine Dose, Relapse and Cost of Opioid Addiction Treatment

Clark, Robin E.
; 
Baxter, Jeffrey D.
; 
Barton, Bruce A
; 
Aweh, Gideon
; 
O'Connell, Elizabeth
; 
Fisher, Bill
Citations
Altmetric:
Authors
Clark, Robin E.
Baxter, Jeffrey D.
Barton, Bruce A
Aweh, Gideon
O'Connell, Elizabeth
Fisher, Bill
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Department of Quantitative Health Sciences
 Department of Family Medicine and Community Health
 Commonwealth Medicine, Center for Health Policy and Research
Document Type
Presentation
Publication Date
2013-07-20
Keywords
Drug addiction treatment
 Medicaid
 buprenorphine
 pharmaceutical policy
 prior authorization
 opioid treatment
 Health Economics
 Health Law and Policy
 Health Policy
 Health Services Administration
 Health Services Research
 Substance Abuse and Addiction
Subject Area
Collections
ForHealth Consulting Publications
Show all metadata
Files
Thumbnail Image
8161_Buprenorphine_PA_AH_6_22_13.pdf
Adobe PDF, 397.68 KB
Embargo Expiration Date
Link to Full Text
Abstract

This presentation discusses the impact of prior authorization on Buprenorphine dose, relapse, and cost for opioid addiction treatment for Massachusetts Medicaid members.

Presented at the AcademyHealth Annual Research Meeting 2013.

Source
Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.13028/kwyc-1452
Permanent Link to this Item
https://hdl.handle.net/20.500.14038/27078
PubMed ID
Other Identifiers
Notes
Funding and Acknowledgements
Corresponding Author
Related Resources
Related Resources
Repository Citation
Rights
Distribution License